SEMA3C Promotes the Progression of Endometriosis by Inducing Ferroptosis and Enhancing the Viability and Migration of Endometrial Stromal Cells

Li Y, Yan Li, Yi Zhang, Zhang Y
Gynecologic and obstetric investigation · 2026 · pp. 1 · doi:10.1159/goi/aczag005 · PMID:42678895 · W7206177403
Lab / animal OA: closed public-domain-us
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-04 ⓘ

This study found that SEMA3C promotes endometriosis progression by enhancing endometrial stromal cell viability and migration through ferroptosis-related oxidative and inflammatory mechanisms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: The aim of this study was to examine SEMA3C expression in endometriosis (EMs) and its relationship with ferroptosis in human endometrial stromal cells (HESCs). DESIGN: This experimental study used patient tissue samples and in vitro gain- and loss-of-function assays. Participants/Materials: The participants and materials involved endometrial tissues from 30 patients with EMs and 30 controls, including paired ectopic and eutopic tissues from 10 patients, and primary HESCs. SETTING: This study was set in the Affiliated Women and Children's Hospital of Ningbo University and its associated laboratory facilities. METHODS: SEMA3C expression was assessed by immunohistochemistry, Western blotting, and qRT-PCR in this study. Primary HESCs were subjected to SEMA3C overexpression or siRNA-mediated knockdown. Cell viability, migration, iron content, lipid peroxidation, antioxidant activity, inflammatory cytokines, and ferroptosis regulators were analyzed. Ferrostatin-1 was used for rescue experiments. RESULTS: This experimental study showed that SEMA3C was upregulated in ectopic tissues versus controls (p < 0.001) and correlated with disease severity (stages III-IV vs. I-II, p < 0.01). Ectopic lesions showed higher SEMA3C mRNA than matched eutopic endometrium (p < 0.001). Ectopic tissues and SEMA3C-overexpressing HESCs showed increased ferroptosis-related oxidative and inflammatory changes. SEMA3C overexpression enhanced HESC viability and migration, increased ACSL4, and decreased Nrf2, GPX4, and SLC7A11 expression (p < 0.001). SEMA3C knockdown or Ferrostatin-1 attenuated these alterations and suppressed HESC viability and migration (p < 0.01). LIMITATIONS: The findings of this study are based on clinical tissues and in vitro HESC experiments, and in vivo validation and prospective confirmation are required. CONCLUSIONS: It was shown thatSEMA3C promotes HESC viability and migration through ferroptosis-related oxidative and inflammatory mechanisms, identifying the SEMA3C-ferroptosis axis as a potential pathogenic pathway in EMs.

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (33)

SciLite annotations

organisms 1
human
chemicals 4
iron lipid ferrostatin-1 ferrostatin-1

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
openalex
last seen: 2026-11-01T06:01:13.392755+00:00
pubmed
last seen: 2026-10-31T06:02:49.666044+00:00
scilite
last seen: 2026-09-27T09:57:59.810255+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine